Human medicines European public assessment report (EPAR): Hycamtin, topotecan, Ovarian Neoplasms,Uterine Cervical Neoplasms,Small Cell Lung Carcinoma, Date of authorisation: 12/11/1996, Revision: 30, Status: Authorised

Case Medical Research ◽

10.31525/cmr-2af10a2 ◽

2020 ◽

Author(s):

Keyword(s):

Lung Carcinoma ◽

Ovarian Neoplasms ◽

Small Cell Lung Carcinoma ◽

Small Cell ◽

Small Cell Lung ◽

Cervical Neoplasms ◽

Cell Lung Carcinoma ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Topotecan Actavis, topotecan, Uterine Cervical Neoplasms,Small Cell Lung Carcinoma, Date of authorisation: 24/07/2009, Revision: 6, Status: Withdrawn

Case Medical Research ◽

10.31525/cmr-cfd680 ◽

2019 ◽

Author(s):

Keyword(s):

Lung Carcinoma ◽

Small Cell Lung Carcinoma ◽

Small Cell ◽

Uterine Cervical Neoplasms ◽

Small Cell Lung ◽

Cervical Neoplasms ◽

Cell Lung Carcinoma ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Topotecan Hospira, topotecan, Uterine Cervical Neoplasms,Small Cell Lung Carcinoma, Date of authorisation: 09/06/2010, Revision: 12, Status: Authorised

Case Medical Research ◽

10.31525/cmr-5014c1 ◽

2018 ◽

Author(s):

Keyword(s):

Lung Carcinoma ◽

Small Cell Lung Carcinoma ◽

Small Cell ◽

Uterine Cervical Neoplasms ◽

Small Cell Lung ◽

Cervical Neoplasms ◽

Cell Lung Carcinoma ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Topotecan Actavis, topotecan, Uterine Cervical Neoplasms,Small Cell Lung Carcinoma, Date of authorisation: 24/07/2009, Revision: 6, Status: Withdrawn

Case Medical Research ◽

10.31525/cmr-d02a7b ◽

2019 ◽

Author(s):

Keyword(s):

Lung Carcinoma ◽

Small Cell Lung Carcinoma ◽

Small Cell ◽

Uterine Cervical Neoplasms ◽

Small Cell Lung ◽

Cervical Neoplasms ◽

Cell Lung Carcinoma ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Topotecan Hospira, topotecan, Uterine Cervical Neoplasms,Small Cell Lung Carcinoma, Date of authorisation: 09/06/2010, Revision: 14, Status: Authorised

Case Medical Research ◽

10.31525/cmr-5871d1 ◽

2019 ◽

Author(s):

Keyword(s):

Lung Carcinoma ◽

Small Cell Lung Carcinoma ◽

Small Cell ◽

Uterine Cervical Neoplasms ◽

Small Cell Lung ◽

Cervical Neoplasms ◽

Cell Lung Carcinoma ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Zirabev, bevacizumab, Colorectal Neoplasms,Breast Neoplasms,Carcinoma, Non-Small-Cell Lung,Carcinoma, Renal Cell,Uterine Cervical Neoplasms, Date of authorisation: 14/02/2019, Revision: 1, Status: Authorised

Case Medical Research ◽

10.31525/cmr-12a1fc3 ◽

2019 ◽

Author(s):

Keyword(s):

Breast Neoplasms ◽

Small Cell Lung Carcinoma ◽

Small Cell ◽

Small Cell Lung ◽

Cervical Neoplasms ◽

Cell Lung Carcinoma ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report ◽

Carcinoma Renal Cell

Download Full-text

Human medicines European public assessment report (EPAR): Mvasi, bevacizumab, Carcinoma, Renal Cell,Peritoneal Neoplasms,Ovarian Neoplasms,Breast Neoplasms,Carcinoma, Non-Small-Cell Lung,Fallopian Tube Neoplasms, Date of authorisation: 14/01/2018, Revision: 3, Status: Authorised

Case Medical Research ◽

10.31525/cmr-4e9a82 ◽

2019 ◽

Author(s):

Keyword(s):

Breast Neoplasms ◽

Ovarian Neoplasms ◽

Small Cell ◽

Small Cell Lung ◽

Assessment Report ◽

Peritoneal Neoplasms ◽

European Public ◽

European Public Assessment Report ◽

Fallopian Tube Neoplasms ◽

Carcinoma Renal Cell

Download Full-text

Human medicines European public assessment report (EPAR): Mvasi, bevacizumab, Carcinoma, Renal Cell,Peritoneal Neoplasms,Ovarian Neoplasms,Breast Neoplasms,Carcinoma, Non-Small-Cell Lung,Fallopian Tube Neoplasms, Date of authorisation: 14/01/2018, Revision: 4, Status: Authorised

Case Medical Research ◽

10.31525/cmr-58719b ◽

2019 ◽

Author(s):

Keyword(s):

Breast Neoplasms ◽

Ovarian Neoplasms ◽

Small Cell ◽

Small Cell Lung ◽

Assessment Report ◽

Peritoneal Neoplasms ◽

European Public ◽

European Public Assessment Report ◽

Fallopian Tube Neoplasms ◽

Carcinoma Renal Cell

Download Full-text

Human medicines European public assessment report (EPAR): Avastin, bevacizumab, Carcinoma, Non-Small-Cell Lung,Breast Neoplasms,Ovarian Neoplasms,Colorectal Neoplasms,Carcinoma, Renal Cell, Date of authorisation: 12/01/2005, Revision: 51, Status: Authorised

Case Medical Research ◽

10.31525/cmr-1b3e44e ◽

2019 ◽

Author(s):

Keyword(s):

Breast Neoplasms ◽

Colorectal Neoplasms ◽

Renal Cell ◽

Ovarian Neoplasms ◽

Small Cell ◽

Small Cell Lung ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report ◽

Carcinoma Renal Cell

Download Full-text

Clinical Features And Outcomes Of Patients With Small Cell Lung Carcinoma; Retrospective Analysis

Acta Medica Anatolia ◽

10.15824/actamedica.65675 ◽

2015 ◽

Vol 3 (2) ◽

pp. 47 ◽

Cited By ~ 1

Author(s):

Duygu Unalmış ◽

Zehra Yasar ◽

Melih Buyuksirin ◽

Gulru Polat ◽

Fatma Demirci Ucsular ◽

...

Keyword(s):

Retrospective Analysis ◽

Clinical Features ◽

Lung Carcinoma ◽

Small Cell Lung Carcinoma ◽

Small Cell ◽

Small Cell Lung ◽

Cell Lung Carcinoma

Download Full-text

Subtyping of non-small cell lung carcinoma in fine needle aspiration specimens: A study of 252 patients with surgical correlation

10.26226/morressier.578f37fcd462b8028d88f270 ◽

2016 ◽

Author(s):

Beyhan Mollamehmetoglu

Keyword(s):

Lung Carcinoma ◽

Fine Needle Aspiration ◽

Small Cell Lung Carcinoma ◽

Needle Aspiration ◽

Small Cell ◽

Small Cell Lung ◽

Cell Lung Carcinoma ◽

Fine Needle

Download Full-text